| Verona Pharma plc VRNA | $101.66M | 62.34 | 6.32M | 0% | +$0 | 0.1 | |
| Eliem Therapeutics, Inc. ELYM | $36.03M | 45.21 | 13.15M | 0% | +$0 | 0.04 | |
| Vor Biopharma Inc. VOR | $53.91M | 33.33 | 22.75M | 0% | +$0 | 0.05 | |
| PepGen Inc. PEPG | $157.14M | 32.98 | 10.69M | +31.45% | +$37.6M | 0.16 | |
| Aerovate Therapeutics, Inc. AVTE | $244.37M | 28.69 | 8.26M | 0% | +$0 | 0.25 | |
| Acumen Pharmaceuticals, Inc. ABOS | $60.47M | 24.85 | 14.93M | 0% | +$0 | 0.06 | |
| Tyra Biosciences, Inc. TYRA | $170.83M | 19.83 | 10.42M | +43.95% | +$52.15M | 0.17 | |
| Fulcrum Therapeutics, Inc. FULC | $109.6M | 18.68 | 11.61M | 0% | +$0 | 0.11 | |
| Janux Therapeutics, Inc. JANX | $345.09M | 17.68 | 9.17M | 0% | +$0 | 0.35 | |
Ascendis Pharma A/S ASND | $1.53B | 17.36 | 10.11M | +<0.01% | +$151,170.00 | 1.54 | |
LENZ Therapeutics, Inc. LENZ | $93.31M | 16.36 | 4.18M | New | +$93.31M | 0.09 | |
Acrivon Therapeutics, Inc. Common Stock ACRV | $34.4M | 15.58 | 4.81M | 0% | +$0 | 0.04 | |
| Nkarta, Inc. NKTX | $116.8M | 15.33 | 10.81M | +38.44% | +$32.43M | 0.12 | |
| Wave Life Sciences Ltd. WVE | $112.31M | 14.86 | 18.2M | 0% | +$0 | 0.11 | |
| Werewolf Therapeutics, Inc. HOWL | $39.82M | 14.14 | 6.14M | 0% | +$0 | 0.04 | |
| 89bio, Inc. ETNB | $148.61M | 12.98 | 12.77M | +11.82% | +$15.71M | 0.15 | |
| iTeos Therapeutics, Inc. ITOS | $60.25M | 12.23 | 4.42M | 0% | +$0 | 0.06 | |
GH Research PLC GHRS | $66.64M | 12.02 | 6.25M | +11.89% | +$7.08M | 0.07 | |
| Solid Biosciences Inc. SLDB | $57.68M | 11.28 | 4.33M | +26.39% | +$12.04M | 0.06 | |
ARS Pharmaceuticals, Inc. SPRY | $111M | 11.21 | 10.86M | +14.81% | +$14.32M | 0.11 | |
Mineralys Therapeutics, Inc. MLYS | $62.63M | 9.77 | 4.85M | +52.62% | +$21.59M | 0.06 | |
| 4D Molecular Therapeutics, Inc. FDMT | $160.94M | 9.77 | 5.05M | +21.34% | +$28.3M | 0.16 | |
| Edgewise Therapeutics, Inc. EWTX | $162.5M | 9.54 | 8.91M | New | +$162.5M | 0.16 | |
| Larimar Therapeutics, Inc. LRMR | $45.88M | 9.48 | 6.05M | New | +$45.88M | 0.05 | |
| Day One Biopharmaceuticals, Inc. DAWN | $129.02M | 8.94 | 7.81M | 0% | +$0 | 0.13 | |
| RxSight, Inc. RXST | $177.58M | 8.84 | 3.44M | +1.13% | +$1.99M | 0.18 | |
| Rhythm Pharmaceuticals, Inc. RYTM | $230.97M | 8.74 | 5.33M | 0% | +$0 | 0.23 | |
| UroGen Pharma Ltd. URGN | $46.25M | 8.53 | 3.08M | 0% | +$0 | 0.05 | |
Longboard Pharmaceuticals, Inc. LBPH | $71.04M | 8.46 | 3.29M | New | +$71.04M | 0.07 | |
| Astria Therapeutics, Inc. ATXS | $62.12M | 8.04 | 4.41M | New | +$62.12M | 0.06 | |
Dianthus Therapeutics, Inc. DNTH | $69.99M | 7.95 | 2.33M | New | +$69.99M | 0.07 | |
| Geron Corporation GERN | $152.47M | 7.79 | 46.2M | 0% | +$0 | 0.15 | |
| Vaxcyte, Inc. PCVX | $560.4M | 7.54 | 8.2M | +3.96% | +$21.35M | 0.56 | |
| C4 Therapeutics, Inc. CCCC | $39.85M | 7.09 | 4.88M | 0% | +$0 | 0.04 | |
| Taysha Gene Therapies, Inc. TSHA | $31.2M | 5.81 | 10.87M | -41.14% | -$21.81M | 0.03 | |
| Cytek Biosciences, Inc. CTKB | $45.69M | 5.19 | 6.81M | 0% | +$0 | 0.05 | |
Dyne Therapeutics, Inc. DYN | $140.67M | 5.08 | 4.95M | New | +$140.67M | 0.14 | |
| Evolent Health, Inc. EVH | $188.09M | 4.94 | 5.74M | +125.02% | +$104.5M | 0.19 | |
| Praxis Precision Medicines, Inc. PRAX | $50.55M | 4.84 | 828,380 | New | +$50.55M | 0.05 | |
Enliven Therapeutics, Inc. ELVN | $37.33M | 4.51 | 2.12M | 0% | +$0 | 0.04 | |
Legend Biotech Corporation LEGN | $384.84M | 3.76 | 6.86M | +9.52% | +$33.45M | 0.39 | |
Avidity Biosciences, Inc. RNA | $83.76M | 3.43 | 3.28M | +33.72% | +$21.12M | 0.08 | |
Apogee Therapeutics, Inc. APGE | $131.43M | 3.38 | 1.98M | 0% | +$0 | 0.13 | |
| MacroGenics, Inc. MGNX | $30.65M | 3.32 | 2.08M | -48.63% | -$29.01M | 0.03 | |
| Structure Therapeutics Inc. GPCR | $64.73M | 3.24 | 1.51M | +210.24% | +$43.87M | 0.07 | |
| Axsome Therapeutics, Inc. AXSM | $79.8M | 2.11 | 1M | 0% | +$0 | 0.08 | |
CG Oncology, Inc. Common stock CGON | $61.35M | 2.1 | 1.4M | New | +$61.35M | 0.06 | |
| Madrigal Pharmaceuticals, Inc. MDGL | $54.61M | 0.96 | 204,500 | 0% | +$0 | 0.06 | |
| Biogen Inc. BIIB | $159.72M | 0.51 | 740,727 | +39% | +$44.82M | 0.16 | |
| Inhibrx, Inc. INBX | $91.94B | <0.01 | 2.63M | -44.33% | -$73.22B | 92.45 |